nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—CA12—Zoledronate—osteoporosis	0.522	1	CbGbCtD
Metolazone—CA5A—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.0161	0.122	CbGpPWpGaD
Metolazone—CA7—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.015	0.113	CbGpPWpGaD
Metolazone—CA5B—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.015	0.113	CbGpPWpGaD
Metolazone—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA2—osteoporosis	0.014	0.106	CbGpPWpGaD
Metolazone—CA12—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.0139	0.105	CbGpPWpGaD
Metolazone—CA4—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.0111	0.0839	CbGpPWpGaD
Metolazone—CA9—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00896	0.0678	CbGpPWpGaD
Metolazone—CA9—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.00311	0.0235	CbGpPWpGaD
Metolazone—Quinethazone—CA2—osteoporosis	0.00207	0.181	CrCbGaD
Metolazone—Methyclothiazide—CA2—osteoporosis	0.00198	0.173	CrCbGaD
Metolazone—Benzthiazide—CA2—osteoporosis	0.00192	0.168	CrCbGaD
Metolazone—Indapamide—CA2—osteoporosis	0.00191	0.167	CrCbGaD
Metolazone—Chlorothiazide—CA2—osteoporosis	0.00191	0.167	CrCbGaD
Metolazone—Chlorthalidone—CA2—osteoporosis	0.00164	0.144	CrCbGaD
Metolazone—CA9—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.00117	0.00887	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—PRDX3—osteoporosis	0.000972	0.00735	CbGpPWpGaD
Metolazone—CA9—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000656	0.00496	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—P4HB—osteoporosis	0.000501	0.00379	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000497	0.00376	CbGpPWpGaD
Metolazone—Arthralgia—Pamidronate—osteoporosis	0.00046	0.00138	CcSEcCtD
Metolazone—Back pain—Conjugated Estrogens—osteoporosis	0.000459	0.00137	CcSEcCtD
Metolazone—Urticaria—Alendronate—osteoporosis	0.000459	0.00137	CcSEcCtD
Metolazone—Epistaxis—Estradiol—osteoporosis	0.000459	0.00137	CcSEcCtD
Metolazone—Anxiety—Pamidronate—osteoporosis	0.000458	0.00137	CcSEcCtD
Metolazone—Ill-defined disorder—Zoledronate—osteoporosis	0.000458	0.00137	CcSEcCtD
Metolazone—Abdominal pain—Alendronate—osteoporosis	0.000457	0.00137	CcSEcCtD
Metolazone—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000457	0.00137	CcSEcCtD
Metolazone—Shock—Risedronate—osteoporosis	0.000456	0.00136	CcSEcCtD
Metolazone—Anaemia—Zoledronate—osteoporosis	0.000456	0.00136	CcSEcCtD
Metolazone—Discomfort—Pamidronate—osteoporosis	0.000454	0.00136	CcSEcCtD
Metolazone—Agitation—Zoledronate—osteoporosis	0.000453	0.00136	CcSEcCtD
Metolazone—Gastrointestinal pain—Calcitriol—osteoporosis	0.00045	0.00135	CcSEcCtD
Metolazone—Abdominal pain—Raloxifene—osteoporosis	0.000449	0.00134	CcSEcCtD
Metolazone—Vision blurred—Conjugated Estrogens—osteoporosis	0.000448	0.00134	CcSEcCtD
Metolazone—Urticaria—Ibandronate—osteoporosis	0.000447	0.00134	CcSEcCtD
Metolazone—Malaise—Zoledronate—osteoporosis	0.000445	0.00133	CcSEcCtD
Metolazone—Abdominal pain—Ibandronate—osteoporosis	0.000445	0.00133	CcSEcCtD
Metolazone—CA5A—Metabolism—FDPS—osteoporosis	0.000443	0.00335	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PKM—osteoporosis	0.000443	0.00335	CbGpPWpGaD
Metolazone—Vertigo—Zoledronate—osteoporosis	0.000443	0.00133	CcSEcCtD
Metolazone—Syncope—Zoledronate—osteoporosis	0.000442	0.00132	CcSEcCtD
Metolazone—Leukopenia—Zoledronate—osteoporosis	0.000441	0.00132	CcSEcCtD
Metolazone—Urticaria—Calcitriol—osteoporosis	0.000437	0.00131	CcSEcCtD
Metolazone—Hepatitis—Estradiol—osteoporosis	0.000437	0.00131	CcSEcCtD
Metolazone—Palpitations—Zoledronate—osteoporosis	0.000436	0.0013	CcSEcCtD
Metolazone—Abdominal pain—Calcitriol—osteoporosis	0.000435	0.0013	CcSEcCtD
Metolazone—Shock—Pamidronate—osteoporosis	0.000434	0.0013	CcSEcCtD
Metolazone—Loss of consciousness—Zoledronate—osteoporosis	0.000433	0.0013	CcSEcCtD
Metolazone—Hypersensitivity—Estropipate—osteoporosis	0.000432	0.00129	CcSEcCtD
Metolazone—Thrombocytopenia—Pamidronate—osteoporosis	0.000431	0.00129	CcSEcCtD
Metolazone—Vomiting—Etidronic acid—osteoporosis	0.000431	0.00129	CcSEcCtD
Metolazone—Cough—Zoledronate—osteoporosis	0.00043	0.00129	CcSEcCtD
Metolazone—Rash—Etidronic acid—osteoporosis	0.000428	0.00128	CcSEcCtD
Metolazone—Dermatitis—Etidronic acid—osteoporosis	0.000427	0.00128	CcSEcCtD
Metolazone—Vertigo—Conjugated Estrogens—osteoporosis	0.000427	0.00128	CcSEcCtD
Metolazone—Syncope—Conjugated Estrogens—osteoporosis	0.000426	0.00127	CcSEcCtD
Metolazone—Hypertension—Zoledronate—osteoporosis	0.000426	0.00127	CcSEcCtD
Metolazone—Hypersensitivity—Alendronate—osteoporosis	0.000426	0.00127	CcSEcCtD
Metolazone—Headache—Etidronic acid—osteoporosis	0.000425	0.00127	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000422	0.00126	CcSEcCtD
Metolazone—Asthenia—Estropipate—osteoporosis	0.000421	0.00126	CcSEcCtD
Metolazone—CA5A—Metabolism—PGLS—osteoporosis	0.00042	0.00318	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GPD2—osteoporosis	0.00042	0.00318	CbGpPWpGaD
Metolazone—Anorexia—Pamidronate—osteoporosis	0.00042	0.00126	CcSEcCtD
Metolazone—Chest pain—Zoledronate—osteoporosis	0.00042	0.00126	CcSEcCtD
Metolazone—Arthralgia—Zoledronate—osteoporosis	0.00042	0.00126	CcSEcCtD
Metolazone—Palpitations—Conjugated Estrogens—osteoporosis	0.00042	0.00126	CcSEcCtD
Metolazone—Insomnia—Risedronate—osteoporosis	0.000419	0.00125	CcSEcCtD
Metolazone—Anxiety—Zoledronate—osteoporosis	0.000418	0.00125	CcSEcCtD
Metolazone—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000417	0.00125	CcSEcCtD
Metolazone—Paraesthesia—Risedronate—osteoporosis	0.000416	0.00125	CcSEcCtD
Metolazone—Pruritus—Estropipate—osteoporosis	0.000415	0.00124	CcSEcCtD
Metolazone—Discomfort—Zoledronate—osteoporosis	0.000415	0.00124	CcSEcCtD
Metolazone—Asthenia—Alendronate—osteoporosis	0.000415	0.00124	CcSEcCtD
Metolazone—Hypersensitivity—Ibandronate—osteoporosis	0.000414	0.00124	CcSEcCtD
Metolazone—Cough—Conjugated Estrogens—osteoporosis	0.000414	0.00124	CcSEcCtD
Metolazone—CA7—Metabolism—PKM—osteoporosis	0.000414	0.00313	CbGpPWpGaD
Metolazone—CA7—Metabolism—FDPS—osteoporosis	0.000414	0.00313	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PKM—osteoporosis	0.000414	0.00313	CbGpPWpGaD
Metolazone—CA5B—Metabolism—FDPS—osteoporosis	0.000414	0.00313	CbGpPWpGaD
Metolazone—Erythema multiforme—Estradiol—osteoporosis	0.000413	0.00124	CcSEcCtD
Metolazone—Dry mouth—Zoledronate—osteoporosis	0.000411	0.00123	CcSEcCtD
Metolazone—Fatigue—Ethinyl Estradiol—osteoporosis	0.00041	0.00123	CcSEcCtD
Metolazone—Pruritus—Alendronate—osteoporosis	0.000409	0.00122	CcSEcCtD
Metolazone—Dyspepsia—Risedronate—osteoporosis	0.000408	0.00122	CcSEcCtD
Metolazone—Tinnitus—Estradiol—osteoporosis	0.000407	0.00122	CcSEcCtD
Metolazone—Constipation—Ethinyl Estradiol—osteoporosis	0.000407	0.00122	CcSEcCtD
Metolazone—Hypersensitivity—Calcitriol—osteoporosis	0.000406	0.00121	CcSEcCtD
Metolazone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000404	0.00121	CcSEcCtD
Metolazone—Chest pain—Conjugated Estrogens—osteoporosis	0.000404	0.00121	CcSEcCtD
Metolazone—Asthenia—Ibandronate—osteoporosis	0.000404	0.00121	CcSEcCtD
Metolazone—Anxiety—Conjugated Estrogens—osteoporosis	0.000403	0.00121	CcSEcCtD
Metolazone—Nausea—Etidronic acid—osteoporosis	0.000403	0.0012	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000401	0.0012	CcSEcCtD
Metolazone—Diarrhoea—Estropipate—osteoporosis	0.000401	0.0012	CcSEcCtD
Metolazone—Fatigue—Risedronate—osteoporosis	0.0004	0.0012	CcSEcCtD
Metolazone—Insomnia—Pamidronate—osteoporosis	0.000399	0.00119	CcSEcCtD
Metolazone—Pruritus—Ibandronate—osteoporosis	0.000398	0.00119	CcSEcCtD
Metolazone—Constipation—Risedronate—osteoporosis	0.000396	0.00119	CcSEcCtD
Metolazone—Pain—Risedronate—osteoporosis	0.000396	0.00119	CcSEcCtD
Metolazone—Shock—Zoledronate—osteoporosis	0.000396	0.00118	CcSEcCtD
Metolazone—Paraesthesia—Pamidronate—osteoporosis	0.000396	0.00118	CcSEcCtD
Metolazone—Diarrhoea—Alendronate—osteoporosis	0.000395	0.00118	CcSEcCtD
Metolazone—Asthenia—Calcitriol—osteoporosis	0.000395	0.00118	CcSEcCtD
Metolazone—Thrombocytopenia—Zoledronate—osteoporosis	0.000394	0.00118	CcSEcCtD
Metolazone—CA7—Metabolism—GPD2—osteoporosis	0.000392	0.00297	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PGLS—osteoporosis	0.000392	0.00297	CbGpPWpGaD
Metolazone—CA7—Metabolism—PGLS—osteoporosis	0.000392	0.00297	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GPD2—osteoporosis	0.000392	0.00297	CbGpPWpGaD
Metolazone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000392	0.00117	CcSEcCtD
Metolazone—Chills—Estradiol—osteoporosis	0.000392	0.00117	CcSEcCtD
Metolazone—Somnolence—Pamidronate—osteoporosis	0.000392	0.00117	CcSEcCtD
Metolazone—Pruritus—Calcitriol—osteoporosis	0.00039	0.00117	CcSEcCtD
Metolazone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000389	0.00116	CcSEcCtD
Metolazone—Diarrhoea—Raloxifene—osteoporosis	0.000389	0.00116	CcSEcCtD
Metolazone—Dyspepsia—Pamidronate—osteoporosis	0.000388	0.00116	CcSEcCtD
Metolazone—Dizziness—Estropipate—osteoporosis	0.000388	0.00116	CcSEcCtD
Metolazone—Diarrhoea—Ibandronate—osteoporosis	0.000385	0.00115	CcSEcCtD
Metolazone—CA5A—Metabolism—ATIC—osteoporosis	0.000384	0.00291	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PNP—osteoporosis	0.000384	0.00291	CbGpPWpGaD
Metolazone—Anorexia—Zoledronate—osteoporosis	0.000384	0.00115	CcSEcCtD
Metolazone—CA12—Metabolism—FDPS—osteoporosis	0.000383	0.0029	CbGpPWpGaD
Metolazone—CA12—Metabolism—PKM—osteoporosis	0.000383	0.0029	CbGpPWpGaD
Metolazone—Decreased appetite—Pamidronate—osteoporosis	0.000383	0.00115	CcSEcCtD
Metolazone—Dizziness—Alendronate—osteoporosis	0.000382	0.00114	CcSEcCtD
Metolazone—Shock—Conjugated Estrogens—osteoporosis	0.000381	0.00114	CcSEcCtD
Metolazone—Fatigue—Pamidronate—osteoporosis	0.00038	0.00114	CcSEcCtD
Metolazone—Gastrointestinal pain—Risedronate—osteoporosis	0.000379	0.00113	CcSEcCtD
Metolazone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000378	0.00113	CcSEcCtD
Metolazone—Constipation—Pamidronate—osteoporosis	0.000377	0.00113	CcSEcCtD
Metolazone—Pain—Pamidronate—osteoporosis	0.000377	0.00113	CcSEcCtD
Metolazone—Diarrhoea—Calcitriol—osteoporosis	0.000377	0.00113	CcSEcCtD
Metolazone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000376	0.00112	CcSEcCtD
Metolazone—Dizziness—Raloxifene—osteoporosis	0.000376	0.00112	CcSEcCtD
Metolazone—Flatulence—Estradiol—osteoporosis	0.000375	0.00112	CcSEcCtD
Metolazone—Tension—Estradiol—osteoporosis	0.000373	0.00112	CcSEcCtD
Metolazone—Vomiting—Estropipate—osteoporosis	0.000373	0.00112	CcSEcCtD
Metolazone—Dysgeusia—Estradiol—osteoporosis	0.000372	0.00111	CcSEcCtD
Metolazone—Dizziness—Ibandronate—osteoporosis	0.000372	0.00111	CcSEcCtD
Metolazone—Rash—Estropipate—osteoporosis	0.00037	0.00111	CcSEcCtD
Metolazone—Dermatitis—Estropipate—osteoporosis	0.000369	0.00111	CcSEcCtD
Metolazone—Anorexia—Conjugated Estrogens—osteoporosis	0.000369	0.00111	CcSEcCtD
Metolazone—Nervousness—Estradiol—osteoporosis	0.000369	0.0011	CcSEcCtD
Metolazone—Urticaria—Risedronate—osteoporosis	0.000368	0.0011	CcSEcCtD
Metolazone—Back pain—Estradiol—osteoporosis	0.000368	0.0011	CcSEcCtD
Metolazone—Headache—Estropipate—osteoporosis	0.000367	0.0011	CcSEcCtD
Metolazone—Vomiting—Alendronate—osteoporosis	0.000367	0.0011	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000367	0.0011	CcSEcCtD
Metolazone—Abdominal pain—Risedronate—osteoporosis	0.000366	0.0011	CcSEcCtD
Metolazone—Muscle spasms—Estradiol—osteoporosis	0.000365	0.00109	CcSEcCtD
Metolazone—Rash—Alendronate—osteoporosis	0.000364	0.00109	CcSEcCtD
Metolazone—Insomnia—Zoledronate—osteoporosis	0.000364	0.00109	CcSEcCtD
Metolazone—Dermatitis—Alendronate—osteoporosis	0.000364	0.00109	CcSEcCtD
Metolazone—CA12—Metabolism—PGLS—osteoporosis	0.000363	0.00275	CbGpPWpGaD
Metolazone—CA12—Metabolism—GPD2—osteoporosis	0.000363	0.00275	CbGpPWpGaD
Metolazone—Feeling abnormal—Pamidronate—osteoporosis	0.000363	0.00109	CcSEcCtD
Metolazone—Headache—Alendronate—osteoporosis	0.000362	0.00108	CcSEcCtD
Metolazone—Paraesthesia—Zoledronate—osteoporosis	0.000361	0.00108	CcSEcCtD
Metolazone—Vomiting—Raloxifene—osteoporosis	0.000361	0.00108	CcSEcCtD
Metolazone—Gastrointestinal pain—Pamidronate—osteoporosis	0.00036	0.00108	CcSEcCtD
Metolazone—CA7—Metabolism—PNP—osteoporosis	0.000359	0.00271	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ATIC—osteoporosis	0.000359	0.00271	CbGpPWpGaD
Metolazone—CA7—Metabolism—ATIC—osteoporosis	0.000359	0.00271	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PNP—osteoporosis	0.000359	0.00271	CbGpPWpGaD
Metolazone—Rash—Raloxifene—osteoporosis	0.000358	0.00107	CcSEcCtD
Metolazone—Dermatitis—Raloxifene—osteoporosis	0.000358	0.00107	CcSEcCtD
Metolazone—Somnolence—Zoledronate—osteoporosis	0.000358	0.00107	CcSEcCtD
Metolazone—Vomiting—Ibandronate—osteoporosis	0.000358	0.00107	CcSEcCtD
Metolazone—Headache—Raloxifene—osteoporosis	0.000356	0.00106	CcSEcCtD
Metolazone—Rash—Ibandronate—osteoporosis	0.000355	0.00106	CcSEcCtD
Metolazone—Dermatitis—Ibandronate—osteoporosis	0.000354	0.00106	CcSEcCtD
Metolazone—Dyspepsia—Zoledronate—osteoporosis	0.000354	0.00106	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000353	0.00106	CcSEcCtD
Metolazone—Ill-defined disorder—Estradiol—osteoporosis	0.000353	0.00106	CcSEcCtD
Metolazone—Headache—Ibandronate—osteoporosis	0.000352	0.00105	CcSEcCtD
Metolazone—Insomnia—Conjugated Estrogens—osteoporosis	0.000351	0.00105	CcSEcCtD
Metolazone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00035	0.00105	CcSEcCtD
Metolazone—Vomiting—Calcitriol—osteoporosis	0.00035	0.00105	CcSEcCtD
Metolazone—Decreased appetite—Zoledronate—osteoporosis	0.00035	0.00105	CcSEcCtD
Metolazone—Agitation—Estradiol—osteoporosis	0.000349	0.00104	CcSEcCtD
Metolazone—Nausea—Estropipate—osteoporosis	0.000348	0.00104	CcSEcCtD
Metolazone—Abdominal pain—Pamidronate—osteoporosis	0.000348	0.00104	CcSEcCtD
Metolazone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000348	0.00104	CcSEcCtD
Metolazone—Rash—Calcitriol—osteoporosis	0.000347	0.00104	CcSEcCtD
Metolazone—Fatigue—Zoledronate—osteoporosis	0.000347	0.00104	CcSEcCtD
Metolazone—Dermatitis—Calcitriol—osteoporosis	0.000347	0.00104	CcSEcCtD
Metolazone—Headache—Calcitriol—osteoporosis	0.000345	0.00103	CcSEcCtD
Metolazone—Somnolence—Conjugated Estrogens—osteoporosis	0.000345	0.00103	CcSEcCtD
Metolazone—Pain—Zoledronate—osteoporosis	0.000344	0.00103	CcSEcCtD
Metolazone—Constipation—Zoledronate—osteoporosis	0.000344	0.00103	CcSEcCtD
Metolazone—Nausea—Alendronate—osteoporosis	0.000343	0.00103	CcSEcCtD
Metolazone—Malaise—Estradiol—osteoporosis	0.000343	0.00103	CcSEcCtD
Metolazone—Hypersensitivity—Risedronate—osteoporosis	0.000342	0.00102	CcSEcCtD
Metolazone—Vertigo—Estradiol—osteoporosis	0.000341	0.00102	CcSEcCtD
Metolazone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000341	0.00102	CcSEcCtD
Metolazone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000341	0.00102	CcSEcCtD
Metolazone—Syncope—Estradiol—osteoporosis	0.000341	0.00102	CcSEcCtD
Metolazone—Nausea—Raloxifene—osteoporosis	0.000337	0.00101	CcSEcCtD
Metolazone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000337	0.00101	CcSEcCtD
Metolazone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000336	0.00101	CcSEcCtD
Metolazone—Palpitations—Estradiol—osteoporosis	0.000336	0.001	CcSEcCtD
Metolazone—Fatigue—Conjugated Estrogens—osteoporosis	0.000334	0.001	CcSEcCtD
Metolazone—Nausea—Ibandronate—osteoporosis	0.000334	0.001	CcSEcCtD
Metolazone—Loss of consciousness—Estradiol—osteoporosis	0.000334	0.000999	CcSEcCtD
Metolazone—Asthenia—Risedronate—osteoporosis	0.000333	0.000995	CcSEcCtD
Metolazone—CA12—Metabolism—PNP—osteoporosis	0.000332	0.00251	CbGpPWpGaD
Metolazone—CA12—Metabolism—ATIC—osteoporosis	0.000332	0.00251	CbGpPWpGaD
Metolazone—Feeling abnormal—Zoledronate—osteoporosis	0.000332	0.000992	CcSEcCtD
Metolazone—Cough—Estradiol—osteoporosis	0.000332	0.000992	CcSEcCtD
Metolazone—Constipation—Conjugated Estrogens—osteoporosis	0.000331	0.000992	CcSEcCtD
Metolazone—Pain—Conjugated Estrogens—osteoporosis	0.000331	0.000992	CcSEcCtD
Metolazone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000329	0.000985	CcSEcCtD
Metolazone—Hypertension—Estradiol—osteoporosis	0.000328	0.000982	CcSEcCtD
Metolazone—Pruritus—Risedronate—osteoporosis	0.000328	0.000981	CcSEcCtD
Metolazone—Nausea—Calcitriol—osteoporosis	0.000327	0.000979	CcSEcCtD
Metolazone—CA5A—Metabolism—OXCT1—osteoporosis	0.000327	0.00247	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CA2—osteoporosis	0.000327	0.00247	CbGpPWpGaD
Metolazone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000325	0.000973	CcSEcCtD
Metolazone—Hypersensitivity—Pamidronate—osteoporosis	0.000325	0.000971	CcSEcCtD
Metolazone—Arthralgia—Estradiol—osteoporosis	0.000324	0.000968	CcSEcCtD
Metolazone—Chest pain—Estradiol—osteoporosis	0.000324	0.000968	CcSEcCtD
Metolazone—Anxiety—Estradiol—osteoporosis	0.000322	0.000965	CcSEcCtD
Metolazone—Urticaria—Zoledronate—osteoporosis	0.00032	0.000957	CcSEcCtD
Metolazone—Discomfort—Estradiol—osteoporosis	0.00032	0.000956	CcSEcCtD
Metolazone—CA5A—Metabolism—MGLL—osteoporosis	0.000318	0.00241	CbGpPWpGaD
Metolazone—Abdominal pain—Zoledronate—osteoporosis	0.000318	0.000952	CcSEcCtD
Metolazone—Diarrhoea—Risedronate—osteoporosis	0.000317	0.000949	CcSEcCtD
Metolazone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000317	0.000948	CcSEcCtD
Metolazone—Dry mouth—Estradiol—osteoporosis	0.000316	0.000947	CcSEcCtD
Metolazone—Asthenia—Pamidronate—osteoporosis	0.000316	0.000946	CcSEcCtD
Metolazone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000314	0.000941	CcSEcCtD
Metolazone—Pruritus—Pamidronate—osteoporosis	0.000312	0.000933	CcSEcCtD
Metolazone—Urticaria—Conjugated Estrogens—osteoporosis	0.000308	0.000921	CcSEcCtD
Metolazone—Dizziness—Risedronate—osteoporosis	0.000307	0.000917	CcSEcCtD
Metolazone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000306	0.000917	CcSEcCtD
Metolazone—CA4—Metabolism—FDPS—osteoporosis	0.000306	0.00231	CbGpPWpGaD
Metolazone—CA4—Metabolism—PKM—osteoporosis	0.000306	0.00231	CbGpPWpGaD
Metolazone—Shock—Estradiol—osteoporosis	0.000305	0.000913	CcSEcCtD
Metolazone—CA5B—Metabolism—OXCT1—osteoporosis	0.000305	0.00231	CbGpPWpGaD
Metolazone—CA7—Metabolism—OXCT1—osteoporosis	0.000305	0.00231	CbGpPWpGaD
Metolazone—CA7—Metabolism—CA2—osteoporosis	0.000305	0.00231	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CA2—osteoporosis	0.000305	0.00231	CbGpPWpGaD
Metolazone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000302	0.000904	CcSEcCtD
Metolazone—Diarrhoea—Pamidronate—osteoporosis	0.000302	0.000902	CcSEcCtD
Metolazone—Rash—Ethinyl Estradiol—osteoporosis	0.0003	0.000897	CcSEcCtD
Metolazone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0003	0.000896	CcSEcCtD
Metolazone—Headache—Ethinyl Estradiol—osteoporosis	0.000298	0.000891	CcSEcCtD
Metolazone—CA7—Metabolism—MGLL—osteoporosis	0.000297	0.00225	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MGLL—osteoporosis	0.000297	0.00225	CbGpPWpGaD
Metolazone—Hypersensitivity—Zoledronate—osteoporosis	0.000297	0.000887	CcSEcCtD
Metolazone—Vomiting—Risedronate—osteoporosis	0.000295	0.000882	CcSEcCtD
Metolazone—Rash—Risedronate—osteoporosis	0.000292	0.000874	CcSEcCtD
Metolazone—Dermatitis—Risedronate—osteoporosis	0.000292	0.000874	CcSEcCtD
Metolazone—Dizziness—Pamidronate—osteoporosis	0.000291	0.000872	CcSEcCtD
Metolazone—Headache—Risedronate—osteoporosis	0.00029	0.000869	CcSEcCtD
Metolazone—CA4—Metabolism—PGLS—osteoporosis	0.00029	0.00219	CbGpPWpGaD
Metolazone—CA4—Metabolism—GPD2—osteoporosis	0.00029	0.00219	CbGpPWpGaD
Metolazone—Asthenia—Zoledronate—osteoporosis	0.000289	0.000864	CcSEcCtD
Metolazone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000286	0.000854	CcSEcCtD
Metolazone—Pruritus—Zoledronate—osteoporosis	0.000285	0.000852	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000283	0.000846	CcSEcCtD
Metolazone—CA12—Metabolism—OXCT1—osteoporosis	0.000283	0.00214	CbGpPWpGaD
Metolazone—CA12—Metabolism—CA2—osteoporosis	0.000283	0.00214	CbGpPWpGaD
Metolazone—Nausea—Ethinyl Estradiol—osteoporosis	0.000282	0.000845	CcSEcCtD
Metolazone—Insomnia—Estradiol—osteoporosis	0.000281	0.000839	CcSEcCtD
Metolazone—Vomiting—Pamidronate—osteoporosis	0.00028	0.000838	CcSEcCtD
Metolazone—Paraesthesia—Estradiol—osteoporosis	0.000279	0.000833	CcSEcCtD
Metolazone—Asthenia—Conjugated Estrogens—osteoporosis	0.000278	0.000832	CcSEcCtD
Metolazone—Rash—Pamidronate—osteoporosis	0.000278	0.000831	CcSEcCtD
Metolazone—Dermatitis—Pamidronate—osteoporosis	0.000278	0.00083	CcSEcCtD
Metolazone—Headache—Pamidronate—osteoporosis	0.000276	0.000826	CcSEcCtD
Metolazone—Somnolence—Estradiol—osteoporosis	0.000276	0.000825	CcSEcCtD
Metolazone—Diarrhoea—Zoledronate—osteoporosis	0.000275	0.000824	CcSEcCtD
Metolazone—CA12—Metabolism—MGLL—osteoporosis	0.000275	0.00208	CbGpPWpGaD
Metolazone—Nausea—Risedronate—osteoporosis	0.000275	0.000824	CcSEcCtD
Metolazone—Pruritus—Conjugated Estrogens—osteoporosis	0.000274	0.00082	CcSEcCtD
Metolazone—Dyspepsia—Estradiol—osteoporosis	0.000273	0.000817	CcSEcCtD
Metolazone—CA5A—Metabolism—IDH2—osteoporosis	0.000271	0.00205	CbGpPWpGaD
Metolazone—Decreased appetite—Estradiol—osteoporosis	0.00027	0.000807	CcSEcCtD
Metolazone—Fatigue—Estradiol—osteoporosis	0.000267	0.0008	CcSEcCtD
Metolazone—Dizziness—Zoledronate—osteoporosis	0.000266	0.000796	CcSEcCtD
Metolazone—Pain—Estradiol—osteoporosis	0.000265	0.000794	CcSEcCtD
Metolazone—Constipation—Estradiol—osteoporosis	0.000265	0.000794	CcSEcCtD
Metolazone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000265	0.000793	CcSEcCtD
Metolazone—CA4—Metabolism—ATIC—osteoporosis	0.000265	0.002	CbGpPWpGaD
Metolazone—CA4—Metabolism—PNP—osteoporosis	0.000265	0.002	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—SOD2—osteoporosis	0.000264	0.002	CbGpPWpGaD
Metolazone—Nausea—Pamidronate—osteoporosis	0.000262	0.000783	CcSEcCtD
Metolazone—Dizziness—Conjugated Estrogens—osteoporosis	0.000256	0.000767	CcSEcCtD
Metolazone—Vomiting—Zoledronate—osteoporosis	0.000256	0.000766	CcSEcCtD
Metolazone—Feeling abnormal—Estradiol—osteoporosis	0.000256	0.000765	CcSEcCtD
Metolazone—CA5A—Metabolism—CYP27A1—osteoporosis	0.000255	0.00192	CbGpPWpGaD
Metolazone—Rash—Zoledronate—osteoporosis	0.000254	0.000759	CcSEcCtD
Metolazone—Gastrointestinal pain—Estradiol—osteoporosis	0.000254	0.000759	CcSEcCtD
Metolazone—Dermatitis—Zoledronate—osteoporosis	0.000254	0.000759	CcSEcCtD
Metolazone—CA5B—Metabolism—IDH2—osteoporosis	0.000253	0.00191	CbGpPWpGaD
Metolazone—CA7—Metabolism—IDH2—osteoporosis	0.000253	0.00191	CbGpPWpGaD
Metolazone—Headache—Zoledronate—osteoporosis	0.000252	0.000754	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—GPX1—osteoporosis	0.000252	0.0019	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ACP5—osteoporosis	0.000248	0.00187	CbGpPWpGaD
Metolazone—CA9—Metabolism—FDPS—osteoporosis	0.000247	0.00187	CbGpPWpGaD
Metolazone—CA9—Metabolism—PKM—osteoporosis	0.000247	0.00187	CbGpPWpGaD
Metolazone—Vomiting—Conjugated Estrogens—osteoporosis	0.000246	0.000737	CcSEcCtD
Metolazone—Urticaria—Estradiol—osteoporosis	0.000246	0.000737	CcSEcCtD
Metolazone—Abdominal pain—Estradiol—osteoporosis	0.000245	0.000734	CcSEcCtD
Metolazone—Rash—Conjugated Estrogens—osteoporosis	0.000244	0.000731	CcSEcCtD
Metolazone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000244	0.00073	CcSEcCtD
Metolazone—Headache—Conjugated Estrogens—osteoporosis	0.000243	0.000726	CcSEcCtD
Metolazone—Nausea—Zoledronate—osteoporosis	0.000239	0.000715	CcSEcCtD
Metolazone—CA5B—Metabolism—CYP27A1—osteoporosis	0.000238	0.0018	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP27A1—osteoporosis	0.000238	0.0018	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPD2—osteoporosis	0.000234	0.00177	CbGpPWpGaD
Metolazone—CA9—Metabolism—PGLS—osteoporosis	0.000234	0.00177	CbGpPWpGaD
Metolazone—CA12—Metabolism—IDH2—osteoporosis	0.000234	0.00177	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ACP5—osteoporosis	0.000231	0.00175	CbGpPWpGaD
Metolazone—CA7—Metabolism—ACP5—osteoporosis	0.000231	0.00175	CbGpPWpGaD
Metolazone—Nausea—Conjugated Estrogens—osteoporosis	0.00023	0.000689	CcSEcCtD
Metolazone—CA5A—Metabolism—TPI1—osteoporosis	0.00023	0.00174	CbGpPWpGaD
Metolazone—Hypersensitivity—Estradiol—osteoporosis	0.000229	0.000684	CcSEcCtD
Metolazone—CA4—Metabolism—CA2—osteoporosis	0.000225	0.0017	CbGpPWpGaD
Metolazone—CA4—Metabolism—OXCT1—osteoporosis	0.000225	0.0017	CbGpPWpGaD
Metolazone—Asthenia—Estradiol—osteoporosis	0.000223	0.000666	CcSEcCtD
Metolazone—CA12—Metabolism—CYP27A1—osteoporosis	0.00022	0.00166	CbGpPWpGaD
Metolazone—CA4—Metabolism—MGLL—osteoporosis	0.00022	0.00166	CbGpPWpGaD
Metolazone—Pruritus—Estradiol—osteoporosis	0.000219	0.000657	CcSEcCtD
Metolazone—CA5A—Metabolism—P4HB—osteoporosis	0.000216	0.00164	CbGpPWpGaD
Metolazone—CA5B—Metabolism—TPI1—osteoporosis	0.000215	0.00163	CbGpPWpGaD
Metolazone—CA7—Metabolism—TPI1—osteoporosis	0.000215	0.00163	CbGpPWpGaD
Metolazone—CA9—Metabolism—PNP—osteoporosis	0.000214	0.00162	CbGpPWpGaD
Metolazone—CA9—Metabolism—ATIC—osteoporosis	0.000214	0.00162	CbGpPWpGaD
Metolazone—CA12—Metabolism—ACP5—osteoporosis	0.000214	0.00162	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GAPDH—osteoporosis	0.000212	0.00161	CbGpPWpGaD
Metolazone—Diarrhoea—Estradiol—osteoporosis	0.000212	0.000635	CcSEcCtD
Metolazone—CA5A—Metabolism—RAP1A—osteoporosis	0.000207	0.00156	CbGpPWpGaD
Metolazone—Dizziness—Estradiol—osteoporosis	0.000205	0.000614	CcSEcCtD
Metolazone—CA5B—Metabolism—P4HB—osteoporosis	0.000202	0.00153	CbGpPWpGaD
Metolazone—CA7—Metabolism—P4HB—osteoporosis	0.000202	0.00153	CbGpPWpGaD
Metolazone—CA12—Metabolism—TPI1—osteoporosis	0.000199	0.00151	CbGpPWpGaD
Metolazone—CA7—Metabolism—GAPDH—osteoporosis	0.000198	0.0015	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GAPDH—osteoporosis	0.000198	0.0015	CbGpPWpGaD
Metolazone—Vomiting—Estradiol—osteoporosis	0.000197	0.00059	CcSEcCtD
Metolazone—Rash—Estradiol—osteoporosis	0.000196	0.000585	CcSEcCtD
Metolazone—Dermatitis—Estradiol—osteoporosis	0.000195	0.000585	CcSEcCtD
Metolazone—Headache—Estradiol—osteoporosis	0.000194	0.000581	CcSEcCtD
Metolazone—CA7—Metabolism—RAP1A—osteoporosis	0.000193	0.00146	CbGpPWpGaD
Metolazone—CA5B—Metabolism—RAP1A—osteoporosis	0.000193	0.00146	CbGpPWpGaD
Metolazone—CA12—Metabolism—P4HB—osteoporosis	0.000187	0.00142	CbGpPWpGaD
Metolazone—CA4—Metabolism—IDH2—osteoporosis	0.000187	0.00141	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000186	0.00141	CbGpPWpGaD
Metolazone—Nausea—Estradiol—osteoporosis	0.000184	0.000551	CcSEcCtD
Metolazone—CA12—Metabolism—GAPDH—osteoporosis	0.000184	0.00139	CbGpPWpGaD
Metolazone—CA9—Metabolism—CA2—osteoporosis	0.000182	0.00138	CbGpPWpGaD
Metolazone—CA9—Metabolism—OXCT1—osteoporosis	0.000182	0.00138	CbGpPWpGaD
Metolazone—CA12—Metabolism—RAP1A—osteoporosis	0.000179	0.00135	CbGpPWpGaD
Metolazone—CA9—Metabolism—MGLL—osteoporosis	0.000177	0.00134	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP27A1—osteoporosis	0.000176	0.00133	CbGpPWpGaD
Metolazone—CA4—Metabolism—ACP5—osteoporosis	0.000171	0.00129	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ENO1—osteoporosis	0.000167	0.00126	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PSMA5—osteoporosis	0.000165	0.00125	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PSMA2—osteoporosis	0.000165	0.00125	CbGpPWpGaD
Metolazone—CA4—Metabolism—TPI1—osteoporosis	0.000159	0.0012	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ENO1—osteoporosis	0.000156	0.00118	CbGpPWpGaD
Metolazone—CA7—Metabolism—ENO1—osteoporosis	0.000156	0.00118	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PSMA2—osteoporosis	0.000154	0.00116	CbGpPWpGaD
Metolazone—CA7—Metabolism—PSMA2—osteoporosis	0.000154	0.00116	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PSMA5—osteoporosis	0.000154	0.00116	CbGpPWpGaD
Metolazone—CA7—Metabolism—PSMA5—osteoporosis	0.000154	0.00116	CbGpPWpGaD
Metolazone—CA9—Metabolism—IDH2—osteoporosis	0.000151	0.00114	CbGpPWpGaD
Metolazone—CA4—Metabolism—P4HB—osteoporosis	0.000149	0.00113	CbGpPWpGaD
Metolazone—CA4—Metabolism—GAPDH—osteoporosis	0.000147	0.00111	CbGpPWpGaD
Metolazone—CA12—Metabolism—ENO1—osteoporosis	0.000145	0.00109	CbGpPWpGaD
Metolazone—CA4—Metabolism—RAP1A—osteoporosis	0.000143	0.00108	CbGpPWpGaD
Metolazone—CA12—Metabolism—PSMA5—osteoporosis	0.000143	0.00108	CbGpPWpGaD
Metolazone—CA12—Metabolism—PSMA2—osteoporosis	0.000143	0.00108	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP27A1—osteoporosis	0.000142	0.00107	CbGpPWpGaD
Metolazone—CA9—Metabolism—ACP5—osteoporosis	0.000138	0.00104	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP19A1—osteoporosis	0.000134	0.00101	CbGpPWpGaD
Metolazone—CA9—Metabolism—TPI1—osteoporosis	0.000128	0.00097	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP19A1—osteoporosis	0.000125	0.000944	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP19A1—osteoporosis	0.000125	0.000944	CbGpPWpGaD
Metolazone—CA9—Metabolism—P4HB—osteoporosis	0.000121	0.000912	CbGpPWpGaD
Metolazone—CA9—Metabolism—GAPDH—osteoporosis	0.000118	0.000895	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP19A1—osteoporosis	0.000116	0.000874	CbGpPWpGaD
Metolazone—CA4—Metabolism—ENO1—osteoporosis	0.000115	0.000872	CbGpPWpGaD
Metolazone—CA9—Metabolism—RAP1A—osteoporosis	0.000115	0.000872	CbGpPWpGaD
Metolazone—CA4—Metabolism—PSMA5—osteoporosis	0.000114	0.00086	CbGpPWpGaD
Metolazone—CA4—Metabolism—PSMA2—osteoporosis	0.000114	0.00086	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ADCY5—osteoporosis	0.000109	0.000826	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GPX1—osteoporosis	0.000109	0.000823	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ADCY5—osteoporosis	0.000102	0.000771	CbGpPWpGaD
Metolazone—CA7—Metabolism—ADCY5—osteoporosis	0.000102	0.000771	CbGpPWpGaD
Metolazone—CA7—Metabolism—GPX1—osteoporosis	0.000102	0.000769	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GPX1—osteoporosis	0.000102	0.000769	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTHFR—osteoporosis	0.0001	0.00076	CbGpPWpGaD
Metolazone—CA12—Metabolism—ADCY5—osteoporosis	9.45e-05	0.000714	CbGpPWpGaD
Metolazone—CA12—Metabolism—GPX1—osteoporosis	9.42e-05	0.000712	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MTHFR—osteoporosis	9.38e-05	0.000709	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTHFR—osteoporosis	9.38e-05	0.000709	CbGpPWpGaD
Metolazone—CA9—Metabolism—ENO1—osteoporosis	9.32e-05	0.000705	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP19A1—osteoporosis	9.22e-05	0.000697	CbGpPWpGaD
Metolazone—CA9—Metabolism—PSMA5—osteoporosis	9.19e-05	0.000695	CbGpPWpGaD
Metolazone—CA9—Metabolism—PSMA2—osteoporosis	9.19e-05	0.000695	CbGpPWpGaD
Metolazone—CA12—Metabolism—MTHFR—osteoporosis	8.69e-05	0.000657	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL6—osteoporosis	8.08e-05	0.000611	CbGpPWpGaD
Metolazone—CA5A—Metabolism—POMC—osteoporosis	8.04e-05	0.000608	CbGpPWpGaD
Metolazone—CA4—Metabolism—ADCY5—osteoporosis	7.54e-05	0.00057	CbGpPWpGaD
Metolazone—CA4—Metabolism—GPX1—osteoporosis	7.51e-05	0.000568	CbGpPWpGaD
Metolazone—CA7—Metabolism—POMC—osteoporosis	7.5e-05	0.000567	CbGpPWpGaD
Metolazone—CA5B—Metabolism—POMC—osteoporosis	7.5e-05	0.000567	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP19A1—osteoporosis	7.45e-05	0.000563	CbGpPWpGaD
Metolazone—CA12—Metabolism—POMC—osteoporosis	6.95e-05	0.000526	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTHFR—osteoporosis	6.93e-05	0.000524	CbGpPWpGaD
Metolazone—CA9—Metabolism—ADCY5—osteoporosis	6.09e-05	0.00046	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX1—osteoporosis	6.07e-05	0.000459	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTHFR—osteoporosis	5.6e-05	0.000423	CbGpPWpGaD
Metolazone—CA4—Metabolism—POMC—osteoporosis	5.54e-05	0.000419	CbGpPWpGaD
Metolazone—CA9—Metabolism—POMC—osteoporosis	4.48e-05	0.000339	CbGpPWpGaD
